Article
Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients.
Clinical immunology (Orlando, Fla.) - 1 Oct 2023
Yakici Nalan, Kreins Alexandra Y, Catak Mehmet Cihangir, Babayeva Royala, Erman Baran, Kenney Heather, Gungor Hatice Eke, Cea Pablo A, Kawai Tomoki, Bosticardo Marita, Delmonte Ottavia Maria, Adams Stuart, Fan Yu-Tong, Pala Francesca, Turkyilmaz Ayberk, Howley Evey, Worth Austen, Kot Hakan, Sefer Asena Pinar, Kara Altan, Bulutoglu Alper, Bilgic-Eltan Sevgi, Altunbas Melek Yorgun, Bayram Catak Feyza, Karakus Ibrahim Serhat, Karatay Emrah, Tekeoglu Sidem Didar, Eser Metin, Albayrak Davut, Citli Senol, Kiykim Ayca, Karakoc-Aydiner Elif, Ozen Ahmet, Ghosh Sujal, Gohlke Holger, Orhan Fazil, Notarangelo Luigi D, Davies E Graham, Baris Safa
Abstract excerpt
Paired box 1 (PAX1) deficiency has been reported in a small number of patients diagnosed with otofaciocervical syndrome type 2 (OFCS2). We described six new patients who demonstrated variable clinical penetrance. Reduced transcriptional activity of pathogenic variants confirmed partial or complete PAX1 deficiency. Thymic aplasia and hypoplasia were associated with impaired T cell immunity. Corrective treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
